GÜVEN, D. C. Et Al. 2022. Impact of Therapy in Patients with Hematologic Malignancies on Seroconversion Rates After SARS-CoV-2 Vaccination. ONCOLOGIST , vol.27 .

GÜVEN, D. C., Sahin, T. K., AKIN, S., & Uckun, F. M., (2022). Impact of Therapy in Patients with Hematologic Malignancies on Seroconversion Rates After SARS-CoV-2 Vaccination. ONCOLOGIST , vol.27.

GÜVEN, DENİZ Et Al. "Impact of Therapy in Patients with Hematologic Malignancies on Seroconversion Rates After SARS-CoV-2 Vaccination," ONCOLOGIST , vol.27, 2022

GÜVEN, DENİZ C. Et Al. "Impact of Therapy in Patients with Hematologic Malignancies on Seroconversion Rates After SARS-CoV-2 Vaccination." ONCOLOGIST , vol.27, 2022

GÜVEN, D. C. Et Al. (2022) . "Impact of Therapy in Patients with Hematologic Malignancies on Seroconversion Rates After SARS-CoV-2 Vaccination." ONCOLOGIST , vol.27.

@article{article, author={DENİZ CAN GÜVEN Et Al. }, title={Impact of Therapy in Patients with Hematologic Malignancies on Seroconversion Rates After SARS-CoV-2 Vaccination}, journal={ONCOLOGIST}, year=2022}